dexmedetomidine has been researched along with Hypoxia-Ischemia, Brain in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 8 (47.06) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, X; Li, L; Peng, Q; Zhou, W | 1 |
| Chen, Y; He, H; Qie, W; Sun, M; Tu, W; Zhou, Y | 1 |
| Dietz, R; Ross, E; Welter, KJ | 1 |
| Gao, H; Liu, Y; Wang, S; Yin, Y; Yu, J; Zhong, Y | 1 |
| Huang, W; Li, X; Wei, Q; Xiao, F | 1 |
| Gao, Q; Li, C; Wu, Z; Xu, Y; Xue, H; Zhang, Y; Zhao, P | 1 |
| Andris, R; Burnsed, J; Elliott, M; Fairchild, K; Heinan, K; Letzkus, L; Zanelli, S | 1 |
| Alonso-Alconada, D; Anderson, B; Bainbridge, A; Broad, KD; Ezzati, M; Fierens, I; Fleiss, B; Golay, X; Gressens, P; Hassell, JK; Hristova, M; Kawano, G; Kaynezhad, P; Price, DL; Robertson, NJ; Rocha-Ferreira, E; Sanders, RD; Tachtsidis, I | 1 |
| Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Shen, M; Sun, CH; Wang, L; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL | 1 |
| Fang, H; Li, HF; Wang, QY; Wang, RR; Yang, M; Zhang, FX; Zhang, JP; Zheng, PC | 1 |
| Fang, H; He, MH; Li, HF; Wang, QY; Wang, RR; Yan, JY; Yang, M; Zhang, FX; Zhang, JP | 1 |
| Anderson, B; Broad, K; Ezzati, M; Faulkner, S; Fierens, I; Fleiss, B; Gressens, P; Hassell, J; Kawano, G; Maze, M; Robertson, NJ; Rostami, J; Sanders, RD; Sleigh, JW | 1 |
| Ma, H; Ren, X; Zuo, Z | 1 |
| Choi, JH; Chung, JY; Han, JH; Jang, MS; Kim, CJ; Kim, SE; Ko, IG; Yi, JW | 1 |
| Aal-Shaya, WA; Al-Faridi, K; Halawani, MM; Taha, WS; Tawfeeq, NA | 1 |
| Haapalinna, A; Kuhmonen, J; Sivenius, J | 1 |
1 review(s) available for dexmedetomidine and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Traumatic brain injury: neuroprotective anaesthetic techniques, an update.
Topics: Adolescent; Adult; Brain Injuries; Cell Death; Central Nervous System Depressants; Craniocerebral Trauma; Cyclosporine; Dexmedetomidine; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Intracranial Hypotension; Isoflurane; Middle Aged; Neuroprotective Agents; Nitrous Oxide; Perioperative Care; Propofol; Resuscitation; Saline Solution, Hypertonic; Xenon; Young Adult | 2009 |
16 other study(ies) available for dexmedetomidine and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Dexmedetomidine Alleviates Hypoxic-Ischemic Brain Damage in Neonatal Rats Through Reducing MicroRNA-134-5p-Mediated NLRX1 Downregulation.
Topics: Animals; Animals, Newborn; Apoptosis; Dexmedetomidine; Down-Regulation; Hippocampus; Hypoxia-Ischemia, Brain; MicroRNAs; Mitochondrial Proteins; Rats | 2022 |
Dexmedetomidine alleviates the hypoxic-ischemic brain damage via miR-20a-5p/methionine adenosyltransferase 2B axis in rat pups.
Topics: Animals; Animals, Newborn; Apoptosis; Dexmedetomidine; Hippocampus; Hypoxia-Ischemia, Brain; Methionine Adenosyltransferase; MicroRNAs; Rats | 2022 |
EBNEO commentary: Dexmedetomidine versus morphine for neonates with encephalopathy undergoing therapeutic hypothermia.
Topics: Dexmedetomidine; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Morphine | 2022 |
Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT/JMJD3 axis.
Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Caspase 1; Dexmedetomidine; Glucose; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Inflammation; Ischemia; MicroRNAs; Pyroptosis; Rats | 2023 |
Dexmedetomidine alleviates the hypoxic-ischemic brain damage via miR-20a-5p/methionine adenosyltransferase 2B axis in rat pups: Erratum.
Topics: Animals; Brain; Dexmedetomidine; Hypoxia-Ischemia, Brain; Methionine Adenosyltransferase; MicroRNAs; Rats | 2023 |
MicroRNA-29a-3p strengthens the effect of dexmedetomidine on improving neurologic damage in newborn rats with hypoxic-ischemic brain damage by inhibiting HDAC4.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Animals, Newborn; Dexmedetomidine; Gene Expression Regulation; Histone Deacetylases; Hypoxia-Ischemia, Brain; Male; MicroRNAs; Rats; Rats, Sprague-Dawley | 2021 |
Dexmedetomidine post-conditioning ameliorates long-term neurological outcomes after neonatal hypoxic ischemia: The role of autophagy.
Topics: Animals; Animals, Newborn; Autophagy; Brain; Cell Death; Dexmedetomidine; Female; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Ischemic Postconditioning; Male; Microglia; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2021 |
Effect of dexmedetomidine on heart rate in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia.
Topics: Dexmedetomidine; Heart Rate; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Retrospective Studies | 2022 |
Dexmedetomidine Combined with Therapeutic Hypothermia Is Associated with Cardiovascular Instability and Neurotoxicity in a Piglet Model of Perinatal Asphyxia.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Cardiovascular System; Combined Modality Therapy; Dexmedetomidine; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Male; Neuroprotective Agents; Random Allocation; Swine | 2017 |
MicroRNA-140-5p elevates cerebral protection of dexmedetomidine against hypoxic-ischaemic brain damage via the Wnt/β-catenin signalling pathway.
Topics: Animals; Animals, Newborn; Apoptosis; beta Catenin; Cell Proliferation; Cerebral Cortex; Dexmedetomidine; Gene Expression Regulation; Humans; Hypoxia-Ischemia, Brain; Hypoxia, Brain; MicroRNAs; Neurons; Rats; Wnt Signaling Pathway; Wnt1 Protein | 2018 |
microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1.
Topics: Animals; Animals, Newborn; Apoptosis; Body Weight; Brain; Dexmedetomidine; Hypoxia-Ischemia, Brain; Injections, Intraventricular; Maze Learning; Mice; MicroRNAs; Neurons; Neuroprotective Agents; Organ Size; Wnt1 Protein | 2019 |
Long non-coding RNA MALAT1 sponges microRNA-429 to regulate apoptosis of hippocampal neurons in hypoxic-ischemic brain damage by regulating WNT1.
Topics: Animals; Apoptosis; Dexmedetomidine; Disease Models, Animal; Hippocampus; Hypoxia-Ischemia, Brain; Mice; Mice, Inbred C57BL; MicroRNAs; Neurons; RNA, Long Noncoding; Wnt1 Protein | 2019 |
Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Asphyxia Neonatorum; Dexmedetomidine; Disease Models, Animal; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Male; Metabolic Clearance Rate; Neuroprotective Agents; Nonlinear Dynamics; Sus scrofa; Swine | 2014 |
Dexmedetomidine Postconditioning Reduces Brain Injury after Brain Hypoxia-Ischemia in Neonatal Rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Animals, Newborn; Brain Injuries; Cerebral Cortex; Dexmedetomidine; Dose-Response Relationship, Drug; Hypoxia-Ischemia, Brain; Ischemic Postconditioning; Maze Learning; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2016 |
Dexmedetomidine promotes the recovery of the field excitatory postsynaptic potentials (fEPSPs) in rat hippocampal slices exposed to oxygen-glucose deprivation.
Topics: Animals; Cell Hypoxia; Dexmedetomidine; Excitatory Postsynaptic Potentials; Glucose; Hippocampus; Hypoxia-Ischemia, Brain; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2016 |
Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Dexmedetomidine; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2001 |